Skip to main content
SpringerLink
Log in
Book cover

Drug Discovery pp 3–18Cite as

Propranolol

  • Chapter

  • 348 Accesses

Abstract

Adrenergic receptor blocking drugs, both alpha and beta, selectively inhibit the effects of norepinephrine, the agonist secreted by adrenergic nerve terminals, and those of epinephrine, the agonist secreted by the adrenal medulla. The dampening of the physiological activities subserved by these endogenous agonists, especially those involving beta agonism, has had considerable and continuing therapeutic significance.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahlquist, R. P.: A study of the adrenotropic receptors. Am. J. Physiol. 153: 586–600, 1948.

    PubMed  CAS  Google Scholar 

  • Alleyne, G. A. O., Dickinson, C. J., Dornhorst, A. C., Fulton, R. M., Green, K. G., Hill, I. D., Hurst, P., Laurance, D. R., Pilkington, T., Prichard, B. N. C., Robinson, B. and Rosenheim, M. L.: Effect of pronethalol in angina pectoris. Br. Med. J. 2:1226,1227,1963.

    Article  PubMed  Google Scholar 

  • Ariens, E. J.: Affinity and intrinsic activity in the theory of competitive inhibition. Part i. Problems and theory. Arch. Int. Pharmacodyn. 99:32–19, 1954.

    PubMed  CAS  Google Scholar 

  • Bennett, D. R., ed.: AMA Drug Evaluations, 5th Ed., American Medical Association, Chicago, 1983.

    Google Scholar 

  • Berkow, R., ed.: Merck Manual, Merck Sharp & Dohme Research Laboratories, Rahway, NJ, 1982.

    Google Scholar 

  • β-Blocker Heart Attack Trial Research Group: A randomized trial of pro-pranolol in patients with acute myocardial infarction: 1. Mortality results. JAMA 247:1707–1714, 1982.

    Article  Google Scholar 

  • Bigger, J. T. and Hoffman, B. F.: Antiarrhythmic drugs, in The Pharmacological Basis of Therapeutics, 7th Ed., A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Murad, eds., pp. 748–805, Macmillan, New York, 1985.

    Google Scholar 

  • Black, J. W.: Ahlquist and the development of beta-adrenoceptor antagonists. Postgrad. Med. J. 52: (Suppl. 4) 11–13, 1976.

    PubMed  Google Scholar 

  • Black, J. W. and Stephenson, J. S.: Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet 2:311–314, 1962.

    Article  PubMed  CAS  Google Scholar 

  • Black, J. W., Crowther, A. F., Shanks, R. G., Smith, L. H., and Dornhorst, A. C: A new adrenergic beta-receptor antagonist. Lancet 1:1080,1081, 1964

    Article  PubMed  CAS  Google Scholar 

  • Braunwald, E., ed.: Symposium on beta adrenergic receptor blockade. Am. J. Cardiol. 18:303–59, 1966.

    Google Scholar 

  • Chess, D. and Yonkman, F. F.: Adrenolytic and sympatholytic actions of priscol (benzyl-imidazoline). Proc. Soc. Exp. Biol. Med. 61:127–130, 1946.

    PubMed  CAS  Google Scholar 

  • Cruickshank, J. M. and Prichard, B. N. C: Beta-bbckers in Clinical Practice, Churchill Livingstone, Edinburgh, 1987.

    Google Scholar 

  • Dale, H. H.: The physiological action of chrysotoxin. J. Physiol. (London) 32: lviii–lx, 1905.

    Google Scholar 

  • Dollery, C. T. and George, C: Propranolol—ten years from introduction. Cardiovascular drug therapy, in Cardiovascular Clinics, K. L. Melmon, ed., pp. 255–268, Davis, Philadelphia, 1974.

    Google Scholar 

  • Dornhorst, A. C. and Robinson, B. F.: Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). Lancet 2: 314–316, 1962.

    Article  PubMed  CAS  Google Scholar 

  • Dunlop, D. and Shanks, R. G.: Selective blockade of adrenoceptive beta receptors in the heart. Br. J. Pharm. Chemother. 32:201–218, 1968.

    Article  CAS  Google Scholar 

  • Fourneau, E. and Bovet, D.: Recherches sur l’action sympathicolytique d’un nouveau dérivé du dioxane. Arch. Int. Pharmacodyn. 46:178–191, 1933.

    CAS  Google Scholar 

  • Frishman, W. H.: Clinical Pharmacology of the Beta-Adrenoceptor Blocking Agents, 2nd Ed., Appleton-Century-Crofts, Norwalk, Connecticut, 1984.

    Google Scholar 

  • Frishman, W. H. and Kostis, J.: The significance of intrinsic sympatho-mimetic activity in beta-adrenoceptor blocking drugs. Cardiovasc. Rev. Reports 3:503–512, 1982.

    Google Scholar 

  • Frishman, W. H., Furberg, C. D., and Friedewald, W. T.: β-Adrenergic blockade for survivors of acute myocardial infarction. N. Engl. J. Med. 310:830–837, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Gill, E. and Vaughan Williams, E. M.: Local anaesthetic activity of the beta-receptor antagonist, pronethalol. Nature 201:199, 1964.

    Article  PubMed  CAS  Google Scholar 

  • Gillam, P.M.S. and Prichard, B.N.C.: Use of propranolol in angina pectoris. Br. Med. J. 2:337–339, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Gillam, P. M. S. and Prichard, B. N. C.: Discovery of the hypotensive effect of propranolol. Postgrad. Med. J. 52: (Suppl. 4): 70–75, 1976.

    PubMed  Google Scholar 

  • Goodman, L.S. and Gilman, A.,eds.: The Pharmacological Basis of Therapeutics. 2nd Ed., Macmillan, New York, 1955.

    Google Scholar 

  • Goodman, L. S. and Gilman, A., eds.: The Pharmacological Basis of Therapeutics. 3rd Ed., Macmillan, New York, 1965.

    Google Scholar 

  • Hamer, J., Grandjean, T., Melendez, L. and Sowton, G. E.: Effect of pro-pranolol (Inderal) in angina pectoris: Preliminary report. Br. Med.J. 2: 720–723, 1964.

    Article  PubMed  CAS  Google Scholar 

  • Hamet, R.: Sur un nouveau cas de inversion des effets adrénaliniques. Compt Rendu. 180:2074–2077, 1925.

    Google Scholar 

  • Hoffbrand, B. I., ed.: Ten years of propranolol. Postgrad. Med. J. 52: (Suppl. 4), 1–192, 1976.

    Google Scholar 

  • Jewitt, D. E. and Singh, B. N.: The role of beta-adrenergic blockade in myo-cardial infarction. Prog. Cardiovasc. Dis. 16:421–438, 1974.

    Article  PubMed  CAS  Google Scholar 

  • Lampe, K. F., ed.: Drug Evaluations, 6th Ed., American Medical Association, Chicago, 1986.

    Google Scholar 

  • Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P., and Brown, T. G.: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597,598,1967.

    Article  PubMed  CAS  Google Scholar 

  • Levy, B.: Alterations of adrenergic responses by N-isopropyl-methoxa-mine.J. Pharmacol. Exp. Ther. 146:129–138, 1964.

    PubMed  CAS  Google Scholar 

  • Levy, B.: The adrenergic blocking activity of N-tert-butylmethoxamine (bu-toxamine). J. Pharmacol. Exp. Ther. 151:413–122, 1966a.

    PubMed  CAS  Google Scholar 

  • Levy, B.:Dimethylisopropylmethoxamine: A selective beta-receptor blocking agent. Br.J. Pharm. Chemother. 27:277–285, 1966b.

    Google Scholar 

  • Lewis, P.: The essential action of propranolol in hypertension. Am.J. Med. 60:837–852, 1976.

    Article  PubMed  CAS  Google Scholar 

  • Lorimer, A. R.: Medical management, in Angina Pectoris, D. G. Julian, ed., pp. 164–187, Churchill Livingstone, Edinburgh, 1985.

    Google Scholar 

  • Moran, N. C. and Perkins, M. E.: Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol.J. Pharmacol. Exp. Ther. 124: 223–237, 1958.

    PubMed  CAS  Google Scholar 

  • Moran, N. C. and Perkins, M. E.: An evaluation of adrenergic blockade of the mammalian heart. J. Pharmacol Exp. Ther. 133:192–201, 1961.

    PubMed  CAS  Google Scholar 

  • Morrelli, H. F.: Propranolol. Diagnosis and treatment drugs: Five years later. Ann. Intern. Med. 78:913–917, 1973.

    PubMed  CAS  Google Scholar 

  • Mueller, H. S. and Ayres, S. M.: The role of propranolol in the treatment of acute myocardial infarction. Prog. Cardiovasc. Dis. 19: 405–412, 1977.

    Article  PubMed  CAS  Google Scholar 

  • Nickerson, M. and Goodman, L.: Pharmacological properties of a new adrenergic blocking agent: N,N-dibenzyl-b-chloroethylamine (dibenamine). J. Pharmacol Exp. Ther. 89:167–185, 1947.

    PubMed  CAS  Google Scholar 

  • Nies, A. S. and Shand, D. G.: Clinical pharmacology of propranolol. Circulation, 52:6–15, 1975.

    Article  PubMed  CAS  Google Scholar 

  • Powell, C. E. and Slater, I. H.: Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J. Pharmacol. Exp. Ther. 122:480–488, 1958.

    PubMed  CAS  Google Scholar 

  • Powell, C. E., Gibson, W. R., and Swanson, E. E.: The pharmacological action of l-O-chlorophenyl-2-isopropylaminoethanol (isoprophenamine) a bronchodilator. J. Am. Pharm. Assoc. 45:785–787, 1956.

    CAS  Google Scholar 

  • Prichard, B. N. C: Hypotensive action of pronethalol. Br. Med. J. 1:1227, 1228,1964.

    Article  PubMed  CAS  Google Scholar 

  • Prichard, B. N. C. and Gillam, P. M. S.: Use of propranolol (Inderal) in treatment of hypertension. Br. Med.. 2:725–727, 1964.

    Article  CAS  Google Scholar 

  • Ross, Jr., J.: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death. Ann. Intern. Med. 84:486,487, 1976.

    PubMed  Google Scholar 

  • Schultz, H. W.: Beta-adrenergic blocking agents. Pharm Index April: 8–15, 1983.

    Google Scholar 

  • Shand, D. G.: Propranolol. N. Engl. J. Med. 293:280–285, 1975.

    Article  PubMed  CAS  Google Scholar 

  • Shanks, R. G.: The pharmacology of beta sympathetic blockade. Am. J. Car-diol. 18:308–316, 1966.

    CAS  Google Scholar 

  • Shanks, R. G.: The properties of beta-adrenoceptor antagonists. Postgrad. Med. J. 52: (Suppl. 4), 14–20, 1976.

    PubMed  Google Scholar 

  • Shanks, R. G.: The discovery of beta-adrenoceptor blocking drugs. Trends Pharmacol. 5:405–409, 1984.

    Article  Google Scholar 

  • Slater, I. H. and Powell, C. E.: Blockade of adrenergic inhibitory receptor sites by l-(3′,4′-dichloropheny1)-2-isopropylaminoethanolhydrochloride. Fed. Proc. 16:336, 1957.

    Google Scholar 

  • Slater, I. H. and Powell, C. E.: Some aspects of blockade of inhibitory adrenergic receptors or adrenoceptive sites. Pharmacol. Rev. 7:462,463,1959.

    Google Scholar 

  • Snow, P.J.D.: Effect of propranolol in myocardial infarction. Lancet 2: 551–553, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Stephenson, R. P.: A modification of receptor theory. Br. J. Pharmacol. 11: 379–393, 1956.

    CAS  Google Scholar 

  • Stock, J. P. P. and Dale, N.: Beta-adrenergic receptor blockade in cardiac arrhythmias. Br. Med. J. 2:1230–1233, 1963.

    Article  PubMed  CAS  Google Scholar 

  • Vaughan Williams, E. M. and Sekiya, A.: Prevention of arrhythmias due to cardiac glycosides by block of sympathetic beta receptors. Lancet 1: 420,421,1963.

    Article  Google Scholar 

  • Weiner, N.: Drugs that inhibit adrenergic nerves and block adrenergic receptors, in The Pharmacological Basis of Therapeutics, 7th Ed., A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Murad, eds., pp. 181–214, Macmillan, New York, 1985.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Wellcome Research Laboratories Research, Triangle Park, North Carolina, USA

    Robert A. Maxwell

  2. University of Vermont College of Medicine, Burlington, Vermont, USA

    Shohreh B. Eckhardt

Authors
  1. Robert A. Maxwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shohreh B. Eckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media New York

About this chapter

Cite this chapter

Maxwell, R.A., Eckhardt, S.B. (1990). Propranolol. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0469-5_1

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6775-1

  • Online ISBN: 978-1-4612-0469-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation